CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (Unaudited) (USD $)	Common Stock	Additional Paid-In Capital	Treasury Stock	Retained Earnings	Accumulated Other Comprehensive income	Total
Beginning Balance, Amount at Dec. 31, 2012	$ 296,033	$ 58,606,942	$ (3,772,410)	$ 20,433,262	$ 2,975,118	$ 78,538,945
Stock-based compensation	2,600	1,513,653				1,516,253
Cancelled/reclass par of unvested restricted stock	(9,477)	9,477
Issuance of stock options for services from non-employees		426,030				426,030
Issuance of common stock upon the exercise of options	400	111,200				111,600
Issuance of common stock in connection with employee stock purchase plan	223	72,192				72,415
Forfeit of restricted common stock in payment of income tax liability	(394)		(208,219)			(208,613)
Issuance of common stock in connection with the Somaxon acquisition	36,576	23,803,848				23,840,424
Issuance of restricted stock in lieu of cash payment	977	103,047				104,024
Cancellation of Put Shares	8,611	6,667,174				6,675,785
Income tax benefit on stock based awards		(84,000)				(84,000)
Net loss				(20,064,702)		(20,064,702)
Reclassification adjustment for net realized gain included in net income (loss), net of income tax					(2,975,118)	(2,975,118)
Ending Balance, Amount at Sep. 30, 2013	$ 335,549	$ 91,229,563	$ (3,980,629)	$ 368,560		$ 87,953,043